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A new journal and new global perspective on
infection control and public health
Andreas Voss1,2*, Jan Kluytmans3,4 and Didier Pittet5,6
With the many changes in healthcare, the occurrence of
new and emerging infectious diseases, and pandemic of
novel resistance mechanisms, the prevention of health-
care-associated infections (HAI) has become increasingly
important. Borders are disappearing - not only between
different healthcare settings locally or nationally - but also
between developed and resource-limited countries,
thereby transforming the fight against HAI into a truly
global challenge. This change is reflected by the World
Health Organization’s (WHO) choice of an infection con-
trol topic for the First Global Patient Safety Challenge -
Clean Care is Safer Care - and the strong focus of the
diagnostic and biomedical industry on HAI prevention
and the control of antimicrobial resistance (AMR).
According to WHO, hundreds of millions of patients
develop HAI every year worldwide and as many as 1.4
million occur each day in hospitals alone [1]. The burden
of disease is obviously much higher in low- and middle-
income countries [2], but it is a challenge in itself to pro-
vide reliable global estimates and data are scarce from
regions of the world where resources are the most lim-
ited [3]. Nevertheless, it is clear that a great number of
global citizens suffer from preventable HAI. HAI are
associated also with huge costs that are no longer afford-
able for most healthcare systems, including those in
resource-rich countries.
AMR and the emergence of new pathogens and/or re-
emergence of old ones are influenced by a large variety of
factors with many far beyond the boundaries of human
medicine and local or even national practices. Pathogens
that were initially strictly hospital-acquired, such as methi-
cillin-resistant Staphylococcus aureus (MRSA), became
community pathogens (CA-MRSA) and even zoonotic
pathogens with the emergence of livestock-associated
(LA)-MRSA, thereby totally changing the epidemiology of
MRSA. CA- and LA-MRSA even pose a serious challenge
to the long admired “search and destroy” strategy. Many
see the local or national prevalence of MRSA as a surro-
gate marker for the quality of infection control, and the
increasing efforts of nations to address the challenge of
ever-increasing MRSA rates seem to produce the right
effect [4,5]. While certainly continuing to be a major chal-
lenge, the tide seems to be changing from Gram-positive
to Gram-negative threats.
Multidrug-resistant Gram-negatives expressing
extended-spectrum beta-lactamases (ESBLs) or carbapene-
mases are already highly prevalent both in the community
and the environment. Recent studies described that most
pieces of retail meat contained ESBL [6]. In addition, New
Delhi metallo-beta-lactamase-1 (NDM-1) was isolated
from drinking water [7]. This creates an unprecedented,
large transmission route and, consequently, the need to
develop new infection control strategies. The resistance
mechanisms involved are not bound to the DNA of a bac-
terial species, but are a transferable genetic element (TGE).
Not a superbug, but a super-TGE![8] The emergence of
TGEs not only increases the opportunity for spread, but
requires new techniques to trace the spread of resistance.
Traditional typing methods are limited to the spread of a
strain and cannot be used to show the spread of TGEs.
The potential for the spread of multidrug-resistant Gram-
negatives seems unlimited. For example, more than 80% of
travellers to India or Pakistan return with ESBLs in their
gastrointestinal tract. These individuals may become a
source of transmission in their home country due to the
potential extended carriage of ESBLs. Indeed, 20% will be
still positive 6 months after their return [9]. The global
population today is highly mobile and problems arising in
faraway countries can no longer be ignored, if we intend to
control the spread of these pathogens.
There is now a pressing need to share knowledge and
experience in HAI prevention and control of AMR with
colleagues from countries and cultures around the world.
This is well reflected by the success of the recent 1st
International Conference on Prevention and Infection
Control (ICPIC 2011) held in Geneva, Switzerland, under
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the auspices of the WHO Collaborating Centre on
Patient Safety. ICPIC was initiated to create a truly inter-
national platform for the exchange of knowledge, best
practices, and cutting-edge research from around the
globe (www.icpic.com). With more than 1200 partici-
pants from 84 nations, the first edition of ICPIC provided
solid proof that many of our colleagues around the world
share our view. An impressive delegation from several
African countries contributed to creating solidarity
between developed and developing countries. In the past,
research and continuing education were driven by a few
North American and European centres, while today a
growing number of centres from around the globe join
ever-increasing efforts to develop measures for the pre-
vention of HAI and AMR spread. Many were represented
at ICPIC, which can be seen as a turning point. The
world will need an increasing number of these centres to
provide expert knowledge and guidance on how to con-
trol HAI and resistance spread in diverse settings, health
systems, and populations.
A logical consequence to ICPIC was to continue our
vision by creating a new journal based on the same ideas.
We are proud to announce the birth of Antimicrobial
Resistance & Infection Control (ARIC), a truly interna-
tional, online, open access journal. ARIC aims to be a glo-
bal forum for all researchers working in the fields related
to the prevention, diagnosis, and treatment of HAI and
AMR development in all health-care settings, systems, and
populations worldwide. A better understanding of factors
contributing to the development and spread of multidrug-
resistant pathogens, possibilities to prevent transmission
and infections, and insight into the difference between
developed countries and countries with limited resources
are key factors to delineate future solutions. ARIC intends
to cover a broad spectrum ranging from preeminent prac-
tices and best available data to the best interventional and
translational research and innovative (technical) develop-
ments in the field of infection control and AMR to over-
come the challenge posed by HAI.
We are convinced that ARIC will become the future
global forum for reports encompassing all aspects of
resistance development and prevention of HAI across all
health-care settings. Prevention of HAI in hospitals,
infection control and AMR in high-risk settings (e.g.
ICUs), HAI prevention and AMR in specific settings e.g.
long-term care facilities or community settings, special
problems with infection control and AMR in resource-
limited countries, and knowledge transfer from devel-
oped to developing and from developing to developed
countries [Syed SB, Dadwal V, Rutter P, Storr J, High-
tower JD, Gooden R, Carlet J, Bagheri Nejad S, Kelley ET,
Donaldson L, Pittet D. Developed-developing country
partnerships: benefits to developed countries. Lancet
2011 (submitted).] are just a few examples of what we
hope to cover.
ARIC’s choice of “open-access” is a logical step
towards its goal to be truly international and to allow
the transfer of knowledge and best practices to even
remote places that cannot afford printed journals. We
realize that open access has financial consequence for
some authors and that the standard BioMed Central
rules to waive article-processing charges may not be
enough. BioMed Central provides an automatic waiver
to authors based in any country classified by the World
Bank as low-income or lower-middle-income economies
[10], but we intend to find solutions in the near future
that will allow us to support authors from upper-middle
income countries and young investigators.
We look forward to welcoming many papers and to
developing this journal with your support into the
online forum for sharing best practices, knowledge, and
latest research with colleagues from around the world.
Andreas Voss - Editor-in-Chief, ARIC
Jan Kluytmans- Deputy Editor, ARIC
Didier Pittet - Executive Editor, ARIC
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